Idiopathic pulmonary fibrosis trials in United Kingdom

In United Kingdom 13 Also abroad 111

13 trials · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

Phase 2Taking people
Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis
Where
Birmingham, Edinburgh, Leicester, London, Perth, Southampton
Age
40 years and over
People
324 worldwide
Run by
Contineum Therapeutics
See details and how to joinNCT07284459 · EU 2025-521901-42-00
Phase 2Taking people
Senicapoc in Patients With Worsening Fibrotic Interstitial Lung Disease
Where
Leicester, Norwich
Age
18 years and over
People
140 worldwide
Run by
Vejle Hospital
See details and how to joinNCT06714123 · EU 2024-511131-97-00
Phase 2Taking people
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
Where
Birmingham, Cambridge, Cottingham, Exeter, Leeds, Leicester, London, Oxford, Stoke-on-Trent
Age
18 years and over
People
340 worldwide
Run by
Avalyn Pharma Inc.
See details and how to joinNCT06951217
Phase 2Taking people
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
Where
Birmingham, Edgbaston, Edinburgh, Exeter, London, Oxford, Trumpington
Age
40 years and over
People
120 worldwide
Run by
Rein Therapeutics
See details and how to joinNCT06968845 · EU 2025-520715-13-00
Phase 3Not yet taking people in United Kingdom
Long-term Extension Study to Evaluate Safety and Tolerability of Admilparant in Participants With Pulmonary Fibrosis
Where
Birmingham, Cambridge, Cottingham, Edinburgh, Leeds, London, Oxford, Peterborough
Age
18 years and over
People
2,380 worldwide
Run by
Bristol-Myers Squibb
See details and how to joinNCT07441408 · EU 2025-522373-10-00
Phase 2Taking people
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
Where
Bristol, Cottingham, Edinburgh, Exeter, Liverpool, London
Age
40 years and over
People
359 worldwide
Run by
AstraZeneca
See details and how to joinNCT07652658
Phase 2Taking people
A Study to Find an Efficacious and Safe Dose of CHF10067 (Zampilimab) in Participants With Idiopathic Pulmonary Fibrosis
Where
Cambridge, Exeter
Age
40 years and over
People
240 worldwide
Run by
Chiesi Farmaceutici S.p.A.
See details and how to joinNCT07516951 · EU 2024-514246-37-00
Phase 2Taking people
AURA-IPF: A Randomized Phase 2 Study to Evaluate the Safety and Efficacy of AP02 (Nintedanib Solution) in IPF
Where
Birmingham, Cambridge, Cottingham, Exeter, Leicester, Liverpool, London, Londonderry, Manchester, Oxford, Perth
Age
40 years and over
People
160 worldwide
Run by
Avalyn Pharma Inc.
See details and how to joinNCT07194382 · EU 2025-523431-19-00
Phase 2Taking people
Study of ABBV-142 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Idiopathic Pulmonary Fibrosis
Where
Cambridge, Edinburgh, London, Norwich, Southampton
Age
40 years and over
People
165 worldwide
Run by
AbbVie
See details and how to joinNCT07230288 · EU 2024-518013-25-00
Phase 3Taking people
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF)
Where
Birmingham, Cambridge, Edinburgh, London, Manchester, Perth
Age
18 years and over
People
698 worldwide
Run by
United Therapeutics
See details and how to joinNCT05943535 · EU 2023-504904-26-00
No phaseTaking people
Pilot Study of Nitrate-rich Beetroot Juice Supplementation in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Where
Southampton
Age
18 years to 85 years
People
16
Run by
University Hospital Southampton NHS Foundation Trust
See details and how to joinNCT06488638
No phaseTaking people
A Pilot Study to Assess Body Mass Composition Measurement Using BIA and Muscle Ultrasound in IPF and PPF Patients on Anti-fibrotic Medications
Where
London
Age
18 years and over
People
30
Run by
Royal Brompton & Harefield NHS Foundation Trust
See details and how to joinNCT07332117
Phase 3Taking people
Treating People With Idiopathic Pulmonary Fibrosis With the Addition of Lansoprazole
Where
Aberdeen, Antrim, Basingstoke, Bath, Birmingham, Blackburn, Blackpool, Bristol, Bury St Edmunds, Cambridge, Cardiff, Carmarthen, Craigavon, Crewe, Doncaster, Dundee, Exeter, Frimley, Harlow, Huddersfield, Hull, Kendal, Leeds, Leicester, Liverpool, London, Londonderry, Luton, Macclesfield, Manchester, Newcastle upon Tyne, North Shields, Norwich, Nottingham, Oxford, Portsmouth, Preston, Sheffield, Shrewsbury, Southampton, Stevenage, Stockton-on-Tees, Stoke-on-Trent, Sunderland, Sutton in Ashfield, Taunton, Teddington, Torquay, Wigan, Wolverhampton, Worcester, York
Age
40 years and over
People
298
Run by
Norfolk and Norwich University Hospitals NHS Foundation Trust
See details and how to joinNCT04965298